Showing results (1-10 of 407) with videos related to
Sort By:
Pageof 41
British Medical Journal|January 30, 1971
Drug-induced pulmonary hypertension?F Follath, F Burkart, W SchweizerEuropean Journal of Clinical Pharmacology|March 17, 1978
Intrinsic sympathomimetic activity of beta-adrenoceptor blocking agentsG Cocco, F Burkart, D Chu, et al.Clinical Cardiology|March 1, 1988
Prospective controlled randomized trial of prophylactic antiarrhythmic therapy in postmyocardial infarction patients with asymptomatic ventricular arrhythmias--study design and initial resultsM Pfisterer, F Burkart, F Follath, et al.Zeitschrift Fur Kardiologie|January 1, 1977
[Early mobilisation after myocardial infarction. A prospective and controlled study (author's transl)]M Pfisterer, W Schweizer, F BurkartJournal of the American College of Cardiology|December 1, 1990
Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)F Burkart, M Pfisterer, W Kiowski, et al.The American Journal of Cardiology|June 1, 1992
Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular functionM Pfisterer, W Kiowski, D Burckhardt, et al.Schweizerische Medizinische Wochenschrift|November 6, 1976
[Hemodynamic changes under metoprolol compared to propranolol in hypertensive patients]M Pfisterer, F Burkart, F R Bühler, et al.Journal of Cardiovascular Pharmacology|February 1, 1987
Acute hemodynamic effects of MDL 19205 in mild congestive heart failureC Cottier, F Follath, W Kiowski, et al.Praxis|July 20, 1999
[New cardiovascular drugs: expanded therapeutic possibilities in coronary heart disease and in heart failure]F FollathSchweizerische Medizinische Wochenschrift|January 11, 2000
[Internal medicine in academic centers: what future?]F FollathPageof 41